The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression

American Journal of Pathology

Volumn 184, Issue 8, 2014, Pages 2342-2354

  Hardin, Heather ^a   Guo, Zhenying ^a   Shan, Weihua ^a   Montemayor Garcia, Celina ^a   Asioli, Sofia ^b   Yu, Xiao Min ^a   Harrison, April D ^a   Chen, Herbert ^a   Lloyd, Ricardo V ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 146B; OCTAMER TRANSCRIPTION FACTOR 4; PAIRED RELATED HOMEOBOX PROTEIN 1; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; HOMEODOMAIN PROTEIN; MIRN146 MICRORNA, HUMAN; PRRX1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER STEM CELL; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID PAPILLARY CARCINOMA; TISSUE MICROARRAY; TUMOR INVASION; UPREGULATION; ANIMAL; CARCINOMA; DISEASE COURSE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; THYROID TUMOR; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HETEROGRAFTS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; THYROID NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84904667968     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.04.011     Document Type: Article

References (53)

1. J.A. Sipos, and E.L. Mazzaferri Thyroid cancer epidemiology and prognostic variables Clin Oncol (R Coll Radiol) 22 2010 395 404
2. S.I. Sherman, J.D. Brierley, M. Sperling, K.B. Ain, S.T. Bigos, D.S. Cooper, B.R. Haugen, M. Ho, I. Klein, P.W. Ladenson, J. Robbins, D.S. Ross, B. Specker, T. Taylor, and H.R. Maxon 3rd Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group Cancer 83 1998 1012 1021
3. T. Kondo, S. Ezzat, and S.L. Asa Pathogenetic mechanisms in thyroid follicular-cell neoplasia Nat Rev Cancer 6 2006 292 306
4. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
5. M. Todaro, F. Iovino, V. Eterno, P. Cammareri, G. Gambara, V. Espina, G. Gulotta, F. Dieli, S. Giordano, R. De Maria, and G. Stassi Tumorigenic and metastatic activity of human thyroid cancer stem cells Cancer Res 70 2010 8874 8885
6. T.F. Davies, R. Latif, N.C. Minsky, and R. Ma Clinical review: the emerging cell biology of thyroid stem cells J Clin Endocrinol Metab 96 2011 2692 2702
7. R.Y. Lin Thyroid cancer stem cells Nat Rev Endocrinol 26 2011 609 616
8. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, N. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
9. J. Yang, and R.A. Weinberg Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev Cell 14 2008 818 829
10. V. Vasko, A.V. Espinosa, W. Scouten, H. He, H. Auer, S. Liyanarachchi, A. Larin, V. Savchenko, G.L. Francis, A. de la Chapelle, M. Saji, and M.D. Ringel Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion Proc Natl Acad Sci USA 104 2007 2803 2808
11. E. Janda, K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug, and S. Grünert Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways J Cell Biol 156 2002 299 313
12. C. Scheel, E.N. Eaton, S.H. Li, C.L. Chaffer, F. Reinhardt, K.J. Kah, G. Bell, W. Guo, J. Rubin, and A.L. Richardson Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in breast Cell 145 2011 926 940
13. M. Sakaki-Yumoto, Y. Katsuno, and R. Derynck TGF-[beta] family signaling in stem cells Biochim Biophys Acta 1830 2013 2280 2296
14. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7 2007 415 428
15. D. Buehler, H. Hardin, W. Shan, C. Montemayor-Garcia, P.S. Rush, S. Asioli, H. Chen, and R.C. Lloyd Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas Mod Pathol 26 2013 54 61
16. P. Salerno, G. Garcia-Rostan, S. Piccinin, T.C. Bencivernga, G. Di Maro, C. Doglioni, F. Basolo, R. Maestro, A. Fusco, M. Santoro, and G. Salvatore TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype J Clin Endocrinol Metab 96 2011 E772 E781
17. D.W. Kim, R.L. Walker, P.S. Meltzer, and S.Y. Cheng Complex temporal changes in TGFbeta oncogenic signaling drive thyroid carcinogenesis in a mouse model Carcinogenesis 34 2013 2389 2400
18. K. Shimozaki, G.D. Clemenson Jr., and F.H. Gage Paired related homeobox protein 1 is a regulator of stemness in adult neural stem/progenitor cells J Neurosci 33 2013 4066 4075
19. T. Susa, T. Kato, S. Yoshida, H. Yako, M. Higuchi, and Y. Kato Paired-related homeodomain proteins Prx1 and Prx2 are expressed in embryonic pituitary stem/progenitor cells and may be involved in the early stage of pituitary differentiation J Neuroendocrinol 24 2012 1201 1212
20. O.H. Ocaña, R. Córcoles, A. Fabra, G. Moreno-Bueno, H. Acloque, S. Vega, A. Barrallo-Gimeno, A. Cano, and M.A. Nieto Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1 Cancer Cell 22 2012 709 724
21. M. Reichert, S. Takano, J. von Burstin, S.B. Kim, J.S. Lee, K. Ihida-Stansbury, C. Hahn, S. Heeg, G. Schneider, A.D. Rhim, B.Z. Stanger, and A.K. Rustigi The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis Genes Dev 27 2013 288 300
22. Y. Takahashi, G. Sawada, J. Kurashige, R. Uchi, T. Matsumura, H. Ueo, Y. Takano, S. Akiyoshi, H. Eguchi, T. Sudo, K. Sugimachi, Y. Doki, M. Mori, and K. Mimori Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer Br J Cancer 109 2013 307 311
23. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
24. M.V. Geraldo, A.S. Yamashita, and E.T. Kimura MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer Oncogene 31 2012 1910 1922
25. M.N. Nikiforova, G.C. Tseng, D. Steward, D. Diorio, and Y.E. Nikiforov MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility J Clin Endocrinol Metab 93 2008 1600 1608
26. P. Pallante, R. Visome, C.M. Croce, and A. Fusco Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas Endocr Relat Cancer 17 2010 F91 F104
27. Y. Liao, M. Zhang, and B. Lönnerdal Growth factor TGF-beta induces intestinal epithelial cell (IEC-6) differentiation: miR-146b as a regulatory component in the negative feedback loop Genes Nutr 8 2013 69 78
28. D.R. Hurst, M.D. Edmonds, G.K. Scott, C.C. Benz, K.S. Vaidya, and D.R. Welch Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis Cancer Res 69 2009 1279 1283
29. K.S. Vaidya, S. Harihar, P.A. Phadke, L.J. Stafford, D.R. Hurst, D.G. Hicks, G. Casey, D.B. DeWald, and D.R. Welch Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling J Biol Chem 283 2008 28354 28360
30. H.S. Elsarraj, S.R. Stecklein, K. Valdez, and F. Behbod Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer J Mammary Gland Biol Neoplasia 17 2012 79 87
31. M. Cicek, R. Fukuyama, D.R. Welch, N. Sizemore, and G. Casey Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity Cancer Res 65 2005 3586 3595
32. F. Pacifico, and A. Leonardi Role of NF-kappaB in thyroid cancer Mol Cell Endocrinol 321 2010 29 35
33. F. Pacifico, E. Crescenzi, S. Mellone, A. Iannetti, N. Porrine, D. Liguoro, F. Moscato, M. Grieco, S. Formisano, and A. Leonardi Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinoma through up-regulation of miR-146a J Clin Endocrinol Metab 95 2010 1421 1430
34. M. Katakowski, B. Buller, X. Zheng, Y. Lu, T. Rogers, O. Osobamiro, W. Sju, F. Jiang, and M. Chopp Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth Cancer Lett 335 2013 201 204
35. M. Katakowski, X. Zheng, F. Jiang, T. Rogers, A. Szalad, and M. Chopp miR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma Cancer Invest 28 2010 1024 1030
36. L.A. Marlow, J. D'Innocenzi, Y. Zhang, S.D. Rohl, S.J. Cooper, T. Sebo, C. Grant, B. McIver, J.L. Kasperbauer, J.T. Wadswart, J.D. Casier, P.W. Kennedy, W.G. Highsmith, O. Clark, D. Milosevic, B. Netzel, K. Cradic, S. Arora, C. Beaudy, S.K. Grebe, M.L. Silverberg, D.O. Azorsa, R.C. Smallridge, and J.A. Copland Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target [Errata appeared in J Clin Endocrinol Metab 2013, 98:4213 and J Clin Endocrinol Metab 2013, 98:4546] J Clin Endocrinol Metab 95 2010 5338 5347
37. A. Fierabracci, M.A. Puglisi, L. Giuliani, S. Mattarocci, and M. Gallinella-Muzi Identification of an adult stem/progenitor cell-like population in the human thyroid J Endocrinol 198 2008 471 487
38. R.S. Sippel, J.E. Carpenter, M. Kunnimalaiyaan, S. Lagerholm, and H. Chen Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells Am J Physiol Gastointest Liver Physiol 285 2003 G245 G254
39. R.G. Hardy, C. Vincente-Dueñas, I. González-Herrero, C. Anderson, T. Flores, S. Hughes, C. Tselepis, J.A. Ross, and I. Sánchez-García Snail family transcription factors are implicated in thyroid carcinogenesis Am J Pathol 171 2007 1037 1046
40. V600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation Cancer Res 65 2005 4238 4245
41. K. Yasui, M. Shimamura, N. Mitsutake, and Y. Nagayama SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells Thyroid 23 2013 989 996
42. J. Braun, C. Hoang-Vu, H. Dralle, and S. Hüttelmaier Downregulation of microRNAs direct the EMT and invasive potential of anaplastic thyroid carcinomas Oncogene 29 2010 4237 4244
43. C. Scheel, and R.A. Weinberg Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links Semin Cancer Biol 22 2012 396 403
44. S. Asioli, L.A. Erickson, T.J. Sebo, J. Zhang, L. Jin, G.B. Thompson, and R.V. Lloyd Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical and molecular study of eight cases Am J Surg Pathol 34 2010 44 52
45. C.C. Lubitz, K.P. Economopoulos, A.C. Pawlak, D. Dias-Santagata, W.C. Faquin, and P.M. Sadow Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile Thyroid 24 2014 958 965
46. R.M. Quiros, H.G. Ding, P. Gattuso, R.A. Prinz, and X. Xiulong Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations Cancer 103 2005 2261 2268
47. M.N. Nikiforova, E.T. Kimura, M. Gandhi, P.W. Biddinger, J.A. Knauf, F. Basolo, Z. Zhu, R. Giannini, G. Salvatore, A. Fusco, M. Santoro, J.A. Fagin, and Y.E. Nikiforov BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas J Clin Endocrinol Metab 88 2003 5399 5404
48. J. Albores-Saavedra, M. Hernandez, S. Sanchez-Sosa, K. Simpson, A. Angeles, and D.E. Hanson Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions Am J Surg Pathol 31 2007 729 736
49. S. Begum, E. Rosenbaum, R. Henrique, Y. Cohen, D. Sidransky, and W.H. Westra BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment Mod Pathol 17 2004 1359 1363
50. T. Takano Fetal cell carcinogenesis of the thyroid: a modified theory based on recent evidence [My Opinion] Endocr J 61 2014 311 320
51. M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, W. Wiechno, B. Gornicka, M. Bogdanska, L. Koperski, A. de la Chapelle, and K. Jazdzewski In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma J Clin Endocrinol Metab 98 2013 E1401 E1409
52. C.K. Chou, K.D. Yang, F.F. Chou, C.C. Huang, Y.W. Lan, Y.F. Lee, H.Y. Kang, and R.T. Liu Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma J Clin Endocrinol Metab 98 2013 E196 E205
53. M. Landriscina, G. Pannone, A. Piscazzi, P. Toti, A. Fabiano, S. Tortorella, R. Occhini, A. Ambrosi, P. Bufo, and M. Cignarelli Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans Thyroid 21 2011 1227 1234